|Action Summary||This regulatory action provides coverage for routine patient costs furnished in connection with a member’s participation in a qualifying clinical trial in accordance with Section 210 of the Consolidated Appropriations Act of 2021 and the Centers for Medicare and Medicaid Services (CMS) State Medicaid Director (SMD) letter #21-005.|
|Chapters Affected||Only affects this chapter.|
|Executive Branch Review||This Action is exempt from Article 2 of the Administrative Process Act, but falls within the Exective Branch and will be reviewed by the Governor's Office.|
|RIS Project||Yes |
Is Federal action a driving factor in this regulatory change? If so, please provide a specific reference to the law, regulation
or court case.
Section 210 of the Consolidated Appropriations Act of 2021 and the Centers for Medicare and Medicaid Services (CMS) State Medicaid Director (SMD) letter #21-005.
|New Periodic Review||This action will not be used to conduct a new periodic review.|
|Name / Title:||Meredith Lee / Policy, Regulations, and Manuals Supervisor|
PRME Division, DMAS
600 E. Broad Street, Suite 1300
Richmond, VA 23219
|Phone:||(804)371-0552 FAX: (804)786-1680 TDD: ()-|